Moreover, Tim-3 can interact with high-mobility group protein B1 (HMGB1) to interfere with the recruitment of nucleic acids into DC endosomes and attenuate the therapeutic efficacy of DNA vaccination and chemotherapy by diminishing the immunogenicity of nucleic acids released from dying tumor cells. Here, HAVCR2 is linked to neoplasm.